Literature DB >> 23786547

Volume dependency for culture of fungi from respiratory secretions and increased sensitivity of Aspergillus quantitative PCR.

Marcin G Fraczek1, Marie B Kirwan, Caroline B Moore, Julie Morris, David W Denning, Malcolm D Richardson.   

Abstract

Diagnosis of aspergillosis is often difficult. We compared fungal yields from respiratory specimens using the Health Protection Agency standard culture method (BSOP57), a higher volume undiluted culture method Mycology Reference Centre Manchester (MRCM) and Aspergillus quantitative real time polymerase chain reaction (qPCR). Sputum, bronchial aspirate and bronchoalveolar lavage (BAL) samples (total 23) were collected from aspergillosis patients. One fraction of all samples was cultured using the MRCM method, one BSOP57 and one was used for qPCR. The recovery rate for fungi was significantly higher by MRCM (87%) than by BSOP57 (8.7%) from all 23 specimens. Sputum samples were 44% positive by MRCM compared to no fungi isolated (0%) by BSOP57. Bronchial aspirates were 75% positive by MRCM and 0% by BSOP57. BAL samples were positive in 20% by MRCM and 10% by BSOP57. qPCR was always more sensitive than culture (95.6%) from all samples. In general, over 100 mould colonies (81 Aspergillus fumigatus) were grown using the MRCM method compared with only one colony from BSOP57. This study provides a reference point for standardisation of respiratory sample processing in diagnostic laboratories. Culture from higher volume undiluted respiratory specimens has a much higher yield for Aspergillus than BSOP57. qPCR is much more sensitive than culture and the current UK method requires revision.
© 2013 Blackwell Verlag GmbH.

Entities:  

Keywords:  Aspergillus; bronchoalveolar lavage; culture; qPCR; sputum

Mesh:

Year:  2013        PMID: 23786547     DOI: 10.1111/myc.12103

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  24 in total

Review 1.  Fungal culture and sensitisation in asthma, cystic fibrosis and chronic obstructive pulmonary disorder: what does it tell us?

Authors:  Catherine H Pashley
Journal:  Mycopathologia       Date:  2014-08-24       Impact factor: 2.574

2.  Prevalence of chronic pulmonary aspergillosis in patients with tuberculosis from Iran.

Authors:  M T Hedayati; Y Azimi; A Droudinia; B Mousavi; A Khalilian; N Hedayati; D W Denning
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-05-24       Impact factor: 3.267

3.  Update on fungal diagnostics.

Authors:  Allen T Griffin; Kimberly E Hanson
Journal:  Curr Infect Dis Rep       Date:  2014-08       Impact factor: 3.725

Review 4.  Molecular Diagnostic Advances in Transplant Infectious Diseases.

Authors:  Brittany A Young; Kimberly E Hanson; Carlos A Gomez
Journal:  Curr Infect Dis Rep       Date:  2019-11-26       Impact factor: 3.725

5.  Challenges in Laboratory Detection of Fungal Pathogens in the Airways of Cystic Fibrosis Patients.

Authors:  Sharon C-A Chen; Wieland Meyer; Catherine H Pashley
Journal:  Mycopathologia       Date:  2017-06-06       Impact factor: 2.574

Review 6.  Progress and challenges in fungal lung disease in cystic fibrosis.

Authors:  Gina Hong
Journal:  Curr Opin Pulm Med       Date:  2022-09-19       Impact factor: 2.868

7.  Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Thomas F Patterson; George R Thompson; David W Denning; Jay A Fishman; Susan Hadley; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren A Marr; Vicki A Morrison; M Hong Nguyen; Brahm H Segal; William J Steinbach; David A Stevens; Thomas J Walsh; John R Wingard; Jo-Anne H Young; John E Bennett
Journal:  Clin Infect Dis       Date:  2016-06-29       Impact factor: 9.079

Review 8.  New Perspectives in the Diagnosis and Management of Allergic Fungal Airway Disease.

Authors:  Andrew J Wardlaw; Eva-Maria Rick; Leyla Pur Ozyigit; Alys Scadding; Erol A Gaillard; Catherine H Pashley
Journal:  J Asthma Allergy       Date:  2021-05-25

Review 9.  Allergic fungal airways disease (AFAD): an under-recognised asthma endotype.

Authors:  Catherine H Pashley; Andrew J Wardlaw
Journal:  Mycopathologia       Date:  2021-05-27       Impact factor: 2.574

10.  Fungal allergy in asthma-state of the art and research needs.

Authors:  David W Denning; Catherine Pashley; Domink Hartl; Andrew Wardlaw; Cendrine Godet; Stefano Del Giacco; Laurence Delhaes; Svetlana Sergejeva
Journal:  Clin Transl Allergy       Date:  2014-04-15       Impact factor: 5.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.